Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

Supplementary Table 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes

<p>Comparisons of WTS profiles between ATMm and BRCA2m to the HRP group.</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Justin Hwang (15925675) (author)
Altres autors:	Xiaolei Shi (15925678) (author), Andrew Elliott (15925681) (author), Taylor E. Arnoff (14963396) (author), Julie McGrath (15078600) (author), Joanne Xiu (15051480) (author), Phillip Walker (15925684) (author), Hannah E. Bergom (15925687) (author), Abderrahman Day (15925690) (author), Shihab Ahmed (15925693) (author), Sydney Tape (15925696) (author), Allison Makovec (15925699) (author), Atef Ali (15925702) (author), Rami M. Shaker (15925705) (author), Eamon Toye (15925708) (author), Rachel Passow (15925711) (author), John R. Lozada (15925714) (author), Jinhua Wang (15925717) (author), Emil Lou (14957109) (author), Kent W. Mouw (15925720) (author), Benedito A. Carneiro (15925723) (author), Elisabeth I. Heath (15024674) (author), Rana R. McKay (15062884) (author), W. Michael Korn (15021032) (author), Chadi Nabhan (15051498) (author), Charles J. Ryan (15037635) (author), Emmanuel S. Antonarakis (14971443) (author)
Publicat:	2025
Matèries:	Cancer Molecular and Cellular Biology Genome Biology Comparative transcriptomics Functional genomics
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Supplementary Figure 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Figure 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Figure 3 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Table 1 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Supplementary Table 2 from Metastatic Prostate Cancers with <i>BRCA2</i> versus <i>ATM</i> Mutations Exhibit Divergent Molecular Features and Clinical Outcomes
per: Justin Hwang (15925675)
Publicat: (2025)

Structural variants of <i>Fragaria vesca</i>
per: Minto Odagiri (22680003)
Publicat: (2025)

Gene expression data of <i>Fragaria vesca</i>
per: Minto Odagiri (22680003)
Publicat: (2025)

Processed snRNA-seq data from wild-type and <i>Pink1</i>-deficient mouse gut
per: Muhammad Junaid (14524523)
Publicat: (2025)

liverRegression code.
per: Amy Stephen (22684448)
Publicat: (2025)

Supplementary Table S2 from Clinical Relevance of <i>BRCA1</i> Promoter Methylation Testing in Patients with Ovarian Cancer
per: Félix Blanc-Durand (15049400)
Publicat: (2025)

Supplementary fig 1 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 2 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 3 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 4 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Supplementary fig 5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

Table S1-S5 from Gene Expression Profiling Identifies Two Chordoma Subtypes Associated with Distinct Molecular Mechanisms and Clinical Outcomes
per: Jiwei Bai (15051797)
Publicat: (2025)

scRNA-seq, Oligodendrocyte-Lineage Meta-Atlas
per: Nicholas Mikolajewicz (11242755)
Publicat: (2025)

Data file 1. Figure 1. Overview of <i>L. loa</i> specimen and genomic representation
per: Jeanne Arline Rajaonarivelo (17282572)
Publicat: (2025)

<b>Demographic History and </b><b>Natural Selection</b><b> Regimes Shape Divergent Genomic Architectures in Two Endangered Island Oaks</b>
per: Wenji Luo (4760160)
Publicat: (2025)

<i>K. pneumoniae</i> genomes represented in amr.watch as of 31 March 2025, filtered by the presence of the carbapenem resistance gene, <i>bla</i><sub>NDM-5</sub>.
per: Sophia David (4172902)
Publicat: (2025)

<b>Evolution of extensive neo-sex chromosomes and PAR shift in </b><b><i>Agapornis</i></b><b> lovebirds (</b><b>Supporting files, FISH raw data)</b>
per: Haoran Luo (16515177)
Publicat: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
per: Eileen M. Boyle (15015425)
Publicat: (2025)

The interactive amr.watch application here shows an overview from 179,518 <i>E. coli</i> genomes available as of 31 March 2025.
per: Sophia David (4172902)
Publicat: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
per: Lenka Stolarova (16547259)
Publicat: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
per: Lenka Stolarova (16547259)
Publicat: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
per: Lenka Stolarova (16547259)
Publicat: (2025)

DeepEvo
per: Juntian Qi (22578974)
Publicat: (2025)

Table S2 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

Table S3 from The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors
per: Elena Llano (14963220)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_549kcpdi6l90nnrnpuorgr1g0q